A股異動 | 邁為股份(300751.SZ)大漲超10%破頂 為市場第五高價股
格隆匯7月29日丨邁為股份(300751.SZ)大幅拉昇漲超10%,最高報628元創歷史新高價,為A股市場第五高價股。暫成交8.43億元,總市值達645億元。邁為股份日前公吿,上半年實現營業收入12.39億元,同比增長32.07%;歸屬於上市公司股東的淨利潤2.52億元,同比增長33.17%。安信證券指,半年報盈利能力顯著優化,定增擴張異質結產能。由於去年下游擴產主要集中在下半年,預計公司下半年增長有望繼續加速。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.